Keppler-Ross Sabine, Douglas Lois, Konopka James B, Dean Neta
Department of Biochemistry and Cell Biology, Stony Brook University, NY 11794, USA.
Eukaryot Cell. 2010 Nov;9(11):1776-87. doi: 10.1128/EC.00156-10. Epub 2010 Sep 10.
The first barrier against infection by Candida albicans involves fungal recognition and destruction by phagocytic cells of the innate immune system. It is well established that interactions between different phagocyte receptors and components of the fungal cell wall trigger phagocytosis and subsequent immune responses, but the fungal ligands mediating the initial stage of recognition have not been identified. Here, we describe a novel assay for fungal recognition and uptake by macrophages which monitors this early recognition step independently of other downstream events of phagocytosis. To analyze infection in live macrophages, we validated the neutrality of a codon-optimized red fluorescent protein (yEmRFP) biomarker in C. albicans; growth, hyphal formation, and virulence in infected mice and macrophages were unaffected by yEmRFP production. This permitted a new approach for studying phagocytosis by carrying out competition assays between red and green fluorescent yeast cells to measure the efficiency of yeast uptake by murine macrophages as a function of dimorphism or cell wall defects. These competition experiments demonstrate that, given a choice, macrophages display strong preferences for phagocytosis based on genus, species, and morphology. Candida glabrata and Saccharomyces cerevisiae are taken up by J774 macrophage cells more rapidly than C. albicans, and C. albicans yeast cells are favored over hyphal cells. Significantly, these preferences are mannan dependent. Mutations that affect mannan, but not those that affect glucan or chitin, reduce the uptake of yeast challenged with wild-type competitors by both J774 and primary murine macrophages. These results suggest that mannose side chains or mannosylated proteins are the ligands recognized by murine macrophages prior to fungal uptake.
抵御白色念珠菌感染的第一道防线涉及固有免疫系统吞噬细胞对真菌的识别与破坏。不同吞噬细胞受体与真菌细胞壁成分之间的相互作用可触发吞噬作用及后续免疫反应,这一点已得到充分证实,但介导识别初始阶段的真菌配体尚未明确。在此,我们描述了一种用于巨噬细胞识别和摄取真菌的新检测方法,该方法可独立于吞噬作用的其他下游事件来监测这一早期识别步骤。为分析活巨噬细胞中的感染情况,我们验证了密码子优化的红色荧光蛋白(yEmRFP)生物标志物在白色念珠菌中的中性;yEmRFP的产生不影响白色念珠菌在感染小鼠和巨噬细胞中的生长、菌丝形成及毒力。这使得通过在红色和绿色荧光酵母细胞之间进行竞争实验来研究吞噬作用成为一种新方法,以测量小鼠巨噬细胞摄取酵母的效率与双态性或细胞壁缺陷的关系。这些竞争实验表明,在有选择的情况下,巨噬细胞基于属、种和形态对吞噬作用表现出强烈偏好。光滑念珠菌和酿酒酵母比白色念珠菌被J774巨噬细胞摄取得更快,并且白色念珠菌酵母细胞比菌丝细胞更受青睐。重要的是,这些偏好依赖于甘露聚糖。影响甘露聚糖而非葡聚糖或几丁质的突变会降低J774和原代小鼠巨噬细胞对野生型竞争者挑战的酵母的摄取。这些结果表明,甘露糖侧链或甘露糖基化蛋白是小鼠巨噬细胞在摄取真菌之前识别的配体。